Literature DB >> 26980741

Factors associated with thrombosis in pediatric patients with systemic lupus erythematosus.

K D Driest1, M S Sturm2, S H O'Brien2, C H Spencer2, J R Stanek2, S P Ardoin2.   

Abstract

OBJECTIVE: The risk of thrombosis is increased in patients with systemic lupus erythematosus (SLE). Few studies have assessed factors associated with thrombosis within the pediatric SLE (pSLE) population. We sought to better characterize these associated factors in pSLE patients using the Childhood Arthritis & Rheumatology Research Alliance (CARRA) registry.
METHODS: Within the CARRA registry, patients with a history of thrombosis were compared to those without. Univariate logistic regression was used to calculate odds ratios. A multivariable logistic regression model was conducted that included variables from the univariate analysis that had a p value < 0.10 and other variables identified as clinically significant from published literature.
RESULTS: Among the 979 pSLE patients in the CARRA registry, 24 (2.5%) patients had a history of arterial thrombosis and 35 (3.6%) of venous thrombosis. In the univariate analysis, the odds ratio of having a thrombotic event were found to be significantly higher in patients with a history of vasculitis, avascular necrosis (AVN), or antiphospholipid antibody (aPL). Similar results were found for vasculitis, AVN, and aPL in the multivariable analysis.
CONCLUSION: Our study of pSLE patients suggests that vasculitis, positive APL, and AVN are associated with thrombotic events in this population.
© The Author(s) 2016.

Entities:  

Keywords:  Systemic lupus erythematosus; antiphospholipid syndrome; avascular necrosis; pediatric; thrombosis; vasculitis

Mesh:

Substances:

Year:  2016        PMID: 26980741     DOI: 10.1177/0961203316638164

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  6 in total

Review 1.  Pediatric antiphospholipid syndrome.

Authors:  Jacqueline A Madison; Yu Zuo; Jason S Knight
Journal:  Eur J Rheumatol       Date:  2019-12-03

2.  Diagnostic dilemma in a 3-year-old girl with acute nephritic syndrome and hematologic abnormalities: Answers.

Authors:  Samantha Innocenti; Silvia Bernardi; Maud Prévot; Antonin Saldmann; Maud Tusseau; Alexandre Belot; Jean-Paul Duong Van Huyen; Olivia Boyer
Journal:  Pediatr Nephrol       Date:  2022-10-17       Impact factor: 3.651

3.  The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months.

Authors:  Timothy Beukelman; Yukiko Kimura; Norman T Ilowite; Kelly Mieszkalski; Marc D Natter; Grendel Burrell; Brian Best; Jason Jones; Laura E Schanberg
Journal:  Pediatr Rheumatol Online J       Date:  2017-04-17       Impact factor: 3.054

Review 4.  Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management.

Authors:  Silvia Rosina; Cecilia Beatrice Chighizola; Angelo Ravelli; Rolando Cimaz
Journal:  Curr Rheumatol Rep       Date:  2021-01-28       Impact factor: 4.592

Review 5.  Managing Antiphospholipid Syndrome in Children and Adolescents: Current and Future Prospects.

Authors:  Aline Garcia Islabão; Vitor Cavalcanti Trindade; Licia Maria Henrique da Mota; Danieli Castro Oliveira Andrade; Clovis Artur Silva
Journal:  Paediatr Drugs       Date:  2021-12-13       Impact factor: 3.022

6.  Lytic Susceptibility, Structure, and Mechanical Properties of Fibrin in Systemic Lupus Erythematosus.

Authors:  Rustem I Litvinov; Rosa M Nabiullina; Laily D Zubairova; Mileusha A Shakurova; Izabella A Andrianova; John W Weisel
Journal:  Front Immunol       Date:  2019-07-16       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.